SCHEMBL5547202

SCHEMBL5547202

O=C(c1ccccc1)[C@@]1(O)[C@@H](CO)O[C@@H](n2ccc(=O)[nH]c2=O)[C@@]1(O)C(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC28A1 O00337 1/20 0.43
SLC28A2 O43868 1/20 0.43
SLC29A1 Q99808 1/20 0.43
SLC28A3 Q9HAS3 1/20 0.43
NT5E P21589 1/20 0.39
POLB P06746 2/20 0.39
HSD17B10 Q99714 1/20 0.39
DUT P33316 2/20 0.37
P2RY2 P41231 4/20 0.37
P2RY4 P51582 1/20 0.37
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
KMT2A Q03164 1/20 0.36
RNASE1 P07998 1/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
P2RY12 Q9H244 2/20 0.34
POLA1 P09884 1/20 0.34
P2RY6 Q15077 1/20 0.34
P2RY14 Q15391 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6545741 0.81 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3NT5E
SCHEMBL9221120 0.80 NT5E (0.36) SLC28A1SLC28A2SLC29A1SLC28A3NT5E
SCHEMBL6256517 0.80 NT5E (0.36) SLC28A1SLC28A2SLC29A1SLC28A3NT5E
SCHEMBL10647012 0.78 P2RY2 (0.51) P2RY2P2RY4CYP3A4CYP2C9P2RY12
SCHEMBL9556690 0.76 SLC28A1 (0.44) SLC28A1SLC28A2SLC29A1SLC28A3NT5E
SCHEMBL8887359 0.75 POLB (0.45) SLC28A1SLC28A2SLC29A1SLC28A3NT5E
SCHEMBL6714493 0.75 SLC28A1 (0.49) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL17372031 0.75 SLC28A1 (0.49) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL17372034 0.75 SLC28A1 (0.49) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL4074082 0.74 SLC28A1 (0.40) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043208-A1 Crystal structure of erythrocyte binding domain of EBA-175 NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2007-02-22 US claimed
US-5071974-A COMPOSITIONS AND METHODS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES HAVING 5'-PHOSPHORYLATED TERMINI AMOCO CORPORATION (US) 1991-12-10 US disclosed
EP-0266168-A2 Compositions and methods for the synthesis of oligonucleotides having 5'-phosphorylated termini AMOCO CORPORATION (US) 1988-05-04 EP disclosed